JPRN-UMIN000006498招募中2 期
Palonosetoron+Aprepitant+Dexamethasone Therapy in patients receiving moderately emetogenic anticancer drugs (EJCG-1001) - Palonosetoron+Aprepitant+Dexamethasone Therapy in patients receiving moderately emetogenic anticancer drugs (EJCG-1001)
East Japan Chesters Group (EJCG)0 个研究点目标入组 90 人开始时间: 2011年10月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Severe complications 2)Symptomatic brain meta 4) Massive pleural or abdominal effusion 5) Intestinal paralysis or ileus 7)Hypersensitivity for PaIonosetron, Aprepitant, Dexamethasone 9) Pregnant or lactating 10) Other patients who are unfit for the study as determined by the attending physician.
研究者
相似试验
已完成
2 期
Palonosetron+Aprepitant+Dexamethasone for moderately emetic chemotherapy induced nausea and voimiting-Phase II studyung cancerJPRN-UMIN000004936iigata Lung Cancer Treatment Group160
已完成
2 期
Palonosetron+Aprepitant+Dexamethasone for highly emetic chemotherapy induced nausea and voimitingJPRN-UMIN000004865iigata Lung Cancer Treatment Group95
已完成
2 期
Study of Aprepitant / Palonosetron / Dexamethasone for nausea and vomiting induced chemotherapy for breast cancer.Breast cancerJPRN-UMIN000004025Saitama Breast Cancer Clinical Study Group(SBCCSG)55
招募中
不适用
Aprepitant, Palonosetron and Dexamethasone Antiemetic Therapy Evaluation trial in germ cell tumor (APDATE)Germ cell tumorJPRN-UMIN000008110Department of Urology, Sapporo Medical University School of Medicine30
尚未招募
2 期
A clinical trial to compare two different drug schedules used for prevention of post-operative nausea and vomiting in patients undergoing total abdominal hysterectomyCTRI/2023/08/056041Prashant Dhatwalia